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Membrane curvatureMembrane-activity of the glycoprotein 41 membrane-proximal external region (MPER) is required for HIV-1
membrane fusion. Consequently, its inhibition results in viral neutralization by the antibody 4E10. Previous
studies suggested that MPER might act during fusion by locally perturbing the viral membrane, i.e., following
a mechanism similar to that proposed for certain antimicrobial peptides. Here, we explore the molecular
mechanism of how MPER permeates lipid monolayers containing cholesterol, a main component of the
viral envelope, using grazing incidence X-ray diffraction and X-ray reﬂectivity. Our studies reveal that helical
MPER forms lytic pores under conditions not affecting the lateral packing order of lipids. Moreover, we
observe an increment of the surface area occupied by MPER helices in cholesterol-enriched membranes,
which correlates with an enhancement of the 4E10 epitope accessibility in lipid vesicles. Thus, our data
support the view that curvature generation by MPER hydrophobic insertion into the viral membrane is func-
tionally more relevant than lipid packing disruption.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The human immunodeﬁciency virus type-1 (HIV-1) enters into
host cells upon fusion of viral and cellular membranes induced by
the envelope glycoprotein (Env) transmembrane gp41 subunit
[1,2]. This fusion event depends on the concerted action of two dif-
ferent gp41 ectodomain structural elements: the six-helix bundle
(6-HB), a helical domain that opens and closes, and two membrane-
transferring hydrophobic regions, the N-terminal fusion peptide (FP)
and the C-terminal membrane-proximal external region (MPER),
which are postulated to insert into the cell target and viral membranes,
respectively [3–5]. The most widely accepted mechanism postulates
that following FP and MPER insertion, folding into the energetically
stable 6-HB brings cell and viral membranes to close apposition.
Compellingmutational analysis by Salzwedel and co-workers [6] pro-
vided the ﬁrst evidence to support MPER involvement in HIV-1 fusion.
MPER is enriched in conserved aromatic residues that mediate its
favorable partitioning from water into the membrane interface [6–9]
(Fig. 1A). Peptide-based structural and functional analyses are consistent
with MPER insertion into the viral membrane external monolayer as an
α-helix [10–12] (Fig. 1B), which would be capable of destabilizing the
lipid bilayer organization during fusion [13,14]. It has been proposed
that the C-terminal “cholesterol recognition/interaction amino acid-UPV/EHU), Departamento de
sco, Aptdo. 644, 48080 Bilbao,
rights reserved.consensus” LWYIK sequence and the following transmembrane domain
residues may contribute toMPER interactions with the viral membrane
interface [9,15]. The functional role played in viral entry by this
conserved domain is additionally supported by the fact that anti-
MPER neutralizing antibodies, such as 4E10, have evolved mechanisms
to recognize membrane-inserted epitopes and block MPER membrane
activity [12,16–19].
Mutagenesis studies corroborate that MPER insertion is not only a
structure-related pattern, but also a requirement for the fulﬁllment of
the membrane-disrupting function during fusion [20]. In those stud-
ies, MPER was replaced with sequences based on the Trp-rich, antimi-
crobial peptide indolicidin. Some of the gp41 mutants retained
activity, thereby suggesting that MPER might disrupt lipid packing
following a mechanism similar to that proposed for antimicrobial
peptides [21–24]. Alternatively, it has been postulated that the shal-
low insertion of MPER into the envelope external leaﬂet before,
during, or even after 6-HB formation, might poise the viral membrane
for fusion [10,25]. Speciﬁcally, MPER asymmetric insertion into one
leaﬂet might generate the bulging out of the viral membrane, while
the curved end-caps of such bulges would be highly fusogenic [26].
Here, we combine structural analyses of the MPER peptide in lipid
vesicles and monolayers to investigate the molecular mechanism of
MPER-inducedmembrane perturbation and its physiological relevance.
Our results reveal that MPER does not affect the lateral packing order of
lipids, but changes its membrane insertion depth and topology in
cholesterol-enriched membranes. This phenomenon correlates with
an increment of the surface area occupied by MPER helices, and the
optimal exposure of the 4E10 epitope. We conclude that insertion of
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layer curvature, rather than cause bilayer rupture.
2. Materials and methods
2.1. Materials
The MPER-derived NEQELLELDKWASLWNWFNITNWLWYIK
(MPERp) peptide (Fig. 1A) was produced by solid-phase synthesis
using Fmoc chemistry as C-terminal carboxamides and puriﬁed by
HPLC. 1-palmitoyl-2-oleoyl-sn-glycero-3-phophocholine (POPC), 1,2-
dipalmitoyl-sn-glycero-3-phophocholine (DPPC) and Cholesterol
(Chol) were purchased from Avanti Polar Lipids (Birmingham, AL, USA).
The N-(5-dimethylaminonaphtalene-1-sulfonyl)-1,2-dihexadecanoyl-
sn-glycero-3-phosphoethanolamine (d-DHPE), 8-aminonaphtalene-1,
3,6-trisulfonic acid sodium salt (ANTS) and p-xylenebis(pyridinium)
bromide (DPX) were obtained from Molecular Probes (Junction City,
OR, USA). Monoclonal 4E10 antibody (MAb4E10) was kindly donated
by D. Katinger (Polynum Inc., Vienna, Austria).
2.2. Circular dichroism
Circular dichroism (CD) measurements were obtained from a
thermally-controlled Jasco J-810 circular dichroism spectropolarimeter
calibrated routinely with (1S)-(+)-10-camphorsulfonic acid, ammoni-
um salt. Samples consisted of co-lyophilized peptide and lipid dissolved
and sonicated in 2 mM Hepes (pH, 7.4) buffer. Spectra of the rec-
onstituted peptide-containing vesicles were measured in a 1 mm
path-length quartz cell initially equilibrated at 25 °C. Data were taken
with a 1 nm band-width at 100 nm/min speed, and the results of 20
scans were averaged.
2.3. Lipid vesicle assays
Large unilamellar vesicles (LUV) were prepared according to the
extrusion method in 5 mM Hepes, 100 mM NaCl (pH 7.4) using mem-
branes with a nominal pore-size of 0.1 μm. Distribution of sizes, esti-
mated by quasielastic light scattering using a Malvern Zeta-Sizer Nano
ZS instrument (Malvern Instruments, Malvern, UK), revealed mean
diameters ranging between 110 and 120 nm for the vesicles used in the
experiments. The vesicle size distribution did not signiﬁcantly change
upon the addition of peptide at the highest tested doses (i.e., 1:100
peptide-to-lipid ratio). Chol content in vesicles was determined after
extrusion by the cholesterol oxidase/peroxidase method (BioSystems,
Barcelona, Spain) and found to be within the experimental error.15 A
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Fig. 1. HIV MPER designation and model for its association with membranes Panel A: sequen
based on the prototypic HXBc2 viral isolate. Panel B: model for the cognate ELDKWASLWN
adopted in detergent micelles was obtained from the Protein Data Bank (PDB ID: 2PV6) a
L669, F673 and I675 are based on electro paramagnetic spectroscopy determinations [12].Vesicle permeabilization was monitored following the release to
the medium of encapsulated ﬂuorescent ANTS (ANTS/DPX assay
[27]). LUV containing 12.5 mM ANTS, 45 mM DPX, 20 mM NaCl and
5 mM Hepes were obtained by separating the unencapsulated mate-
rial by gel-ﬁltration in a Sephadex G-75 column that was eluted
with 5 mM Hepes and 100 mM NaCl (pH 7.4). Fluorescence measure-
ments were performed by setting the ANTS emission at 520 nm and
the excitation at 355 nm. A cutoff ﬁlter (470 nm) was placed between
the sample and the emission monochromator. The baseline leakage
(0%) corresponded to the ﬂuorescence of the vesicles at time 0,
while 100% leakage was the ﬂuorescence value obtained after addi-
tion of Triton X-100 (0.5% v/v).
Partitioning into the membrane interface was measured as a function
of time by energy transfer from the Trp peptide to the surface d-DHPE
ﬂuorescent probe as in reference [16]. In brief, 6 mol% of the d-DHPE
probe was included in the target vesicle composition and its ﬂuorescence
wasmeasured at an emissionwavelength of 510 nm,while the excitation
wavelength was that of the Trp residue (280 nm).2.4. Grazing incidence X-ray diffraction (GIXD) and X-ray reﬂectivity
(XR)
Both GIXD and XR are well-established techniques for studying
Langmuir monolayers at the air–liquid interface. Liquid surface X-ray
scattering experiments were performed at the 9-ID beam line at the
Advanced Photon Source, Argonne National Laboratory (Argonne, IL).
The liquid surface spectrometer (LSS) and Langmuir trough chamber
have previously been described [28]. The resolution for the in-plane
scattering angle θXY was set to 1.4 mrad (9.56×10–3 Å−1) by a Soller
collimator. This corresponds to an area uncertainty of 0.027 Å2. Lang-
muir monolayers composed of DPPC/cholesterol with 13 and 46 mol%
of cholesterol were used to mimic the virion membrane with depleted
and regular content of cholesterol, respectively. Lipid monolayers were
formed by depositing droplets of respective solution at the air–liquid
interface and after equilibrating for 15 min compressed to the surface
pressure of 20 mN/m. The solution of a peptide was then evenly injected
underneath themonolayers using amicro-syringewith an L-shaped nee-
dle tomake up the ﬁnal concentration of 0.57 μM,while the surface pres-
sure was kept constant via proportional-integral-derivative feedback
control. Injected peptides interact with the lipid monolayer and result in
an increase in the surface pressure when incorporated into the ﬁlm. To
keep the surface pressure constant, the surface area would have to in-
crease. The resulting relative change in mean molecular area, ΔA/A, was
monitored for up to 180 min after insertion. The experiments wereI675
4E10
SLWNWF673-674NITNWLWYIK683
4E10
ce of MPER peptide used in this study. 4E10 epitope residues underlined. Numbering is
WFNITNWLWYIK peptide in association with a membrane monolayer. The structure
nd rendered using Swiss-PDB-viewer. The insertion depths for the depicted residues
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Fig. 2. Secondary structure and MPERp activity as a function of the Chol content in the bilayer. A) CD spectra of MPERp in association with PC vesicles containing different Chol mole
ratios as indicated in the panels. The lipid and peptide concentrations were 1 mM and 30 μM, respectively. B) Effect of Chol on MPERp-induced ANTS leakage kinetics. The peptide
was added to a vesicle suspension (100 μM lipid) at the time indicated by the arrow (t=50 s). The peptide-to-lipid ratio was 1:150. Chol mole fractions are indicated for each curve.
The dotted traces follow peptide incorporation into the vesicles monitored through energy transfer from tryptophans to membrane-residing d-DHPE.
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magnesium (D-PBS) (Invitrogen) at a room temperature of 22±1 °C.
The R&K trough (Riegler & Kirstein GmbH) sealed in an air-tight
canister was ﬂushed with humidiﬁed helium for X-ray measurements
to reduce X-ray absorption and sample damage. The wavelength of
the beam of λ=0.92017 Å was set by a cryogenically cooled Si (111)
double-crystal monochromator (Kohzu Seiki Co. Ltd.). A split ion cham-
ber monitor and feedback control of the second crystal of the Kohzu
monochromator maintained the position of the beam at the monitor
(9 m before the sample). Ge (111) steering crystal was used to deﬁne
the striking angle of the beam onto liquid surface. Incident slits were
2 mmwide and 50 μm high; detector slits were 2×2 mm2.
In reﬂectivity experiments, scattering intensity is collected as a func-
tion of the out-of-plane scattering vector qZ=(2π/λ)sinαf, αf being the
angle of the diffraction beam with the horizontal plane, using a single-
channel scintillation detector. XR data were analyzed using both
model-dependent (MD) “slab” model reﬁnement [22,23,29] and
model-independent (MI) stochastic ﬁtting routines employing
RFIT2000 (Oleg Konovalov, ESRF) and StochFit software, respectively.
To improve sensitivity of X-ray diffraction to the interface, the
depth of beam penetration is limited by adjusting the incident angle
αi to 0.85αc, with αc being the critical angle for total reﬂection. A
scattering intensity was collected using linear position-sensitive
Mythen detector. A scan over a range of qxy integrated over qz yields
Bragg peaks of a 2D periodic structure. A position of the Bragg peak
maximum deﬁnes a repeat distance dhk of the 2D lattice structure.
The coherence length of the crystallinities can be estimated from
the full-width at half-maximum (FWHM) of the Bragg peaks using
the Scherrer formula L=0.9×2π/FWHM.
3. Results
3.1. MPERp structure and activity in Chol-containing vesicles
The synthetic sequence used in this study, MPERp can be considered
as the canonicalMPERpeptide (Fig. 1A). Themodel for the structure of acognate peptide in membranes (Fig. 1B) displays a kinked structure
with the N-terminus protruding from the bilayer surface and pre-
dominantly exposed to the aqueous phase, while the C-terminal re-
gion containing the 4E10 epitope remains essentially buried in the
membrane [12]. Such model was rendered combining the nuclear
magnetic resonance structure of the peptide dissolved in detergent,
with electro paramagnetic spectroscopy determinations of insertion
depths in bilayers, which included anionic phospholipids [12]. How-
ever, lipidomic analyses reveal that Chol concentrates at the HIV-1
envelope (ca. 45 mol%, [30]). These high concentrations seem to
reﬂect a functional requirement for cell entry, since interference
with [31,32], or depletion of this compound [33,34], abolishes HIV
infectivity. Hence, it is inferred that MPER membrane activity, and
its inhibition by the 4E10 antibody, evolve in the context of this
Chol-enriched membrane. Moreover, Chol modiﬁes the membrane-
interacting properties of peptides [35], and, therefore, is predicted
to exert a physiologically relevant modulation of MPER secondary
structure, orientation and/or insertion level, as well as of its purport-
ed membrane-perturbing activity.
The circular dichroism (CD) analysis displayed in Fig. 2A indicate
that the main secondary structure adopted in contact with mem-
branes by MPERp was similar upon inclusion of high quantities of
Chol. The CD spectra showed major band components at 208 and
222 nm for MPERp in POPC, POPC:Chol (2:1, molar ratio) and POPC:
Chol (1:1, molar ratio) vesicles, therefore indicating that an overall
helical conformation was preserved in all cases. In addition, the
lower absorption suggests that non-helical conformations (strand/
coil) may contribute more to the peptide structure in the latter sam-
ples. The leakage data revealed the existence of different membrane
activities for these helical structures (Fig. 2B). The leakage process
exhibited a transition from slow to fast kinetics upon inclusion of
Chol in the lipid composition (solid lines). As judged from the energy
transfer from Trp-s to membrane-interface residing dansyl moieties
(dotted lines), the slower leakage observed for vesicles devoid of
Chol was not a consequence of a reduction in the rate of peptide in-
corporation into vesicles.
A B
Fig. 3. Grazing incidence X-ray diffraction data (symbols) and corresponding ﬁts (lines): scattering intensity, integrated over qZ range, against scattering vector qXY of (A) DPPC/Chol
(87:13, molar ratio) monolayer before (rhombs) and after MPERp (inverted triangles) injection; (B) DPPC/Chol (54:46, molar ratio) monolayer before (rhombs) and after MPERp
(inverted triangles) injection.
Table 1
Grazing incidence X-ray diffraction data.
Experiment d-Spacing, Å Unit cell parameters a, b (Å),
γ (°), and area A (Å2)
Coherence
length (Å)
13:87 d(1,1),(1,−1)=4.55
d(0,2)=4.30
a=5.37, b=8.6, γ=90,
A=46.2
L(1,1),(1,−1)
=52 L(0,2)=301
+ MPERp d(1,1),(1,−1)=4.53
d(0,2)=4.27
a=5.34, b=8.54, γ=90,
A=45.6
L(1,1),(1,−1)
=36 L(0,2)=174
46:54 4.69 a=b=5.41, γ=120,
A=25.3
58
+ MPERp 4.81 a=b=5.55, γ=120,
A=26.7
23
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containing Chol
The use of Langmuir monolayers allows us to imitate the in vivo sit-
uation when MPER comes in contact with the outer leaﬂet of the virion
membrane. The GIXD technique provides direct structural information
on a nanoscale lateral molecular order in Langmuir monolayers and
has been earlier applied to the analysis of membrane permeabilization
mechanisms by antimicrobial peptides [22,23,29,36,37]. Particularly,
GIXD measurements of peptide-containing phospholipid monolayers
disclosed the capacity of LL-37 or protegrin for selectively disrupting
the structure of monolayers made of anionic phospholipid [22,23].
Hence, to gain insights into the mechanism of MPER-induced mem-
brane perturbation and its modulation by Chol, we performed GIXD
analyses of phospholipid monolayers with low and high levels of Chol,
in the presence and absence of MPERp (Fig. 3 and Table 1).
Using constant-pressure insertion assays we ﬁrst tested the pro-
pensity of the peptide to incorporate into DPPC/cholesterol (87:13,
molar ratio) and (54:46, molar ratio) mixed monolayers at the con-
stant surface pressure of 20 mN/m. The ﬁnal relative increase in
mean molecular area, ΔA/A, upon introduction of MPERp comprised
22% in DPPC/cholesterol (87:13) monolayer and 71% in DPPC/cholesterol
(54:46) ﬁlm. GIXD analyses of these ﬁlms revealed that inserted MPERp
was not capable of disrupting the in-plane order of themixedmonolayers
completely, as follows from the preserved diffraction peaks (Fig. 4). This is
in contrast towhatwas found for LL-37 [22], which induced disappearing
of Bragg peaks, consistent with lipid packing disruption by the peptide
under conditions of effective membrane permeabilization.
Data in Table 1 further indicate that MPERp's insertion into (54:46)
mixture results in the increased unit cell area, whereas insertion into
(87:13) mixed ﬁlm leads to an opposite effect on the unit cell area.
The diffraction of DPPC/cholesterol monolayers is due to the lipid hy-
drophobic region spanning DPPC acyl chains and cholesterol ring
body. Peptide insertion into the headgroup region would create voids
in the monolayer hydrophobic region resulting in a less dense packing
of the acyl chains and cholesterol molecules in the ordered domains.
Therefore, an increase in the unit cell area would be consistent with
MPERp insertion mainly taking place at the lipid headgroups of the
(54:46) mixture. On the other hand, deep peptide penetration into
the ﬁlm hydrophobic core may create additional stress on the lipid
acyl chains and force them to pack denser. Thus, the GIXD data indirect-
ly support deeper MPERp insertion into the (87:13) mixture.
3.3. Insertion depth and topology in phospholipid monolayers containing
Chol
Changes inMPERp's depth of penetrationwere directlymeasured by
X-ray reﬂection measurements (XR) of the ﬁlms. Analysis of XR datayields information on the electron density distribution in a monolayer
in a direction perpendicular to the interface ρ(z) averaged over beam
footprint and thus over ordered and disordered regions of the ﬁlm.
Changes in ρ(z) after introduction of MPERp can be related to a depth
of membrane insertion, orientation within a ﬁlm, and interfacial
concentration, lipid-to-peptide ratio, of the peptide (Table 2). Fig. 4
displays the reﬂectivity curves from the monolayers before and after
introduction of MPERp. The XR curves for the ﬁlms were ﬁtted using a
previously introduced three-slab model for Chol-containing mono-
layers [28]. Following the notation in Table 2, the DPPCAC+CHOLAC
slab corresponds to the layer closest to the air, which includes the acyl
chains, the DPPCAC+CHOLRB slab denotes an intermediate region that
includes the rest of DPPC acyl chains and the cholesterol rigid-ring
body structure, and the DPPCHG+CHOLHG slab corresponds to the bot-
tom layer closest to aqueous buffer comprising the headgroups. Each
of these slabs is characterized by an individual electron density (ρi)
and thickness (Li) (Table 2). Variation of the number of extra electrons
(e−extra) among the different slabs indicates that MPERp peptide pene-
trated deep into the hydrophobic core of DPPC/cholesterol (87:13) ﬁlm
(most of the extra electrons are within the 1st and 2nd slabs). However,
when cholesterol concentration was increased to 46 mol%, the number
of electrons increased signiﬁcantly at the headgroup region (3rd slab),
consistent with a shallow insertion of MPERp into the ﬁlm. In addition,
the surface area occupied by each peptide (Apeptide) was comparatively
higher in this system (Table 2). The lower penetration and the higher
surface occupancy in the (54:46) monolayer were matched by a
peptide-induced decrease of the monolayer's thickness (LT). Such thick-
ness reduction actually occurred within the DPPCAC+CHOLAC and
DPPCAC+CHOLRB regions (compare Li values).
3.4. Chol effect on 4E10 epitope accessibility
The previous monolayer results suggest that MPERp topology was
signiﬁcantly altered upon inclusion of Chol. The physiological relevance
of this phenomenonwas further tested using the 4E10 antibody (Fig. 5).
A B
Fig. 4. X-ray reﬂectivity data (symbols) and corresponding ﬁts (lines) normalized by Fresnel reﬂectivity plotted against scattering vector qZ of (A) DPPC/Chol (87:13, molar ratio)
monolayer before (rhombs) and after MPERp (inverted triangles) injection; (B) DPPC/Chol (54:46, molar ratio) monolayer before (rhombs) and after MPERp (inverted triangles)
injection.
2525A. Ivankin et al. / Biochimica et Biophysica Acta 1818 (2012) 2521–2528This antibody speciﬁcally recognizes the C-terminal sequence of
MPER (Fig. 1), and is capable of arresting peptide-induced mem-
brane permeabilization (Fig. 5A) [16,19,38]. As shown in Fig. 5B,
the inhibitory effect of the antibody increased upon inclusion of
Chol in the membrane composition. The data also show a correlation
between antibody effectiveness and MPERp insertion level into the
monolayers (Fig. 5B and C). Thus, results displayed in this ﬁgure
demonstrate a Chol-induced enhancement of 4E10 epitope accessi-
bility, which correlates with a preferential location of the MPERp
within the headgroup region of the membrane.4. Discussion
A widely accepted model proposes that MPER might help in
remodeling of the merging membranes along the HIV-1 fusion path-
way by sustaining transient disruption of lipid continuity [5,7,20,39].
Alternatively, it has been suggested that MPER hydrophobic inser-
tion into one monolayer might alter the bilayer elastic properties,
thereby priming the viral membrane for fusion [26,40]. In this
work, using Langmuir lipid monolayers and X-ray scattering tech-
niques, we have investigated the mechanism underlying the mem-
brane activity of MPER and evaluated the effect exerted by high
Chol levels. The fact that the peptide–lipid interactions that weTable 2
Results of X-ray reﬂectivity data analysis.
Slab Li (Å) ρi (e−/Å3)exp ρi (e−/Å3)est e−extra
DPPC/cholesterol (87:13)
DPPCAC+CHOLAC 7.9 0.311 NA NA
DPPCAC+CHOLRB 7.5 0.331
DPPCHG+CHOLHG 8.9 0.424
DPPC/cholesterol (87:13)+MPERp
DPPCAC+CHOLAC+MPERp 8.3 0.301 0.243 28
DPPCAC+CHOLRB+MPERp 7.6 0.359 0.268 40.3
DPPCHG+CHOLHG+MPERp 7.7 0.410 0.402 3.6
DPPC/cholesterol (54:46)
DPPCAC+CHOLAC 7.5 0.281 NA NA
DPPCAC+CHOLRB 9.9 0.359
DPPCHG+CHOLHG 7.1 0.417
DPPC/cholesterol (54:46)+MPERp
DPPCAC+CHOLAC+MPERp 5.7 0.26 0.216 17.5
DPPCAC+CHOLRB+MPERp 6.8 0.463 0.306 74.6
DPPCHG+CHOLHG+MPERp 8.0 0.367 0.216 84.4
AC — acyl chains; RB — ring body of cholesterol; HG — headgroups; L — slab thickness; ρex
density of a slab; e−extra — number of extra electrons in a slab; e−extra total — total number o
molecule; L:P100 and L:P50 — lipid-to-peptide ratio assuming 100% and 50% hydration of pemeasured were indeed modulated by Chol underscores the physio-
logical relevance of our ﬁndings.
In a previous single-vesicle study [41], we found that MPERp (termed
as NpreTM in that study) induced transient (“graded”) permeabilization
of giant unilamellar vesicles (GUVs) made of pure POPC. This phenome-
non was characterized by slow kinetics and resulted in most instances
in partial permeabilization of the individual vesicles. Notably, inclusion
of Chol in the lipid composition increased the fraction of the vesicle pop-
ulation permeabilized according to an “all-or-none” mechanism, a
process characterized by fast kinetics and total permeabilization of vesi-
cles. Results in Fig. 2 suggest that a similar Chol-dependent change in
the permeabilization mechanism occurred within the bulk vesicle popu-
lation, but that such phenomenon was not due to an alteration of the
overall helical conformation adopted by the peptide. In the case of the
POPC:Chol (1:1 molar ratio) vesicles, the decrease in CD absorption
further suggests that an increase of MPERp ﬂexibility might contribute
to enhanced permeability rate.
Our X-ray scattering experiments provided a molecular mecha-
nism to explain Chol effects on MPERp membrane activity. The
GIXD data displayed in Fig. 3 and Table 1 reveal that, in contrast to
what is observed for antimicrobial peptides [22,23], MPERp did not
disrupt the integrity of the monolayers. Thus, MPER peptide did not
seem to perturb the organization of lipids according to the mecha-
nisms proposed for antimicrobial peptides [21,24,42]. Furthermore,e−extra total σ (Å) LT (Å) A (Å2) L:P100 L:P50 Apeptide (Å2)
NA 3.3±0.2 24.3 47.7 NA NA NA
71.9 3.3±0.1 23.6 58.2 36:1 32:1 336–378
NA 3.1±0.2 24.5 40.9 NA
176.5 3.2±0.4 20.5 69.9 15:1 13:1 377–435
p — experimental average electron density of a slab; ρest — estimated average electron
f extra electrons in a ﬁlm; LT — total thickness of the ﬁlm; A — area per an average lipid
ptide's polar groups; Apeptide — estimated area per a peptide molecule.
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Fig. 5. Inhibition of MPERp-induced vesicle contents leakage by 4E10. A) Effect of antibody addition to the ongoing leakage. POPC:Chol (2:1, molar ratio) vesicle samples (100 μM
lipid) were treated with 1 μM peptide and, subsequently supplemented with 10 μg/ml of 4E10 (addition time indicated by the arrow). The dotted traces follow the leakage kinetics
in the absence of antibody. B) 4E10-induced inhibition percentages plotted as a function of the Chol mole fraction. Rate reduction caused by antibody with respect to the leakage
control without antibody was calculated by correcting 0% extent of leakage to the time point of antibody addition, and subsequently measuring increment of leakage after 20 s in
both samples. C) Peptide mass percentage distribution between the monolayer slabs under the experimental conditions used for X-ray scattering assays (indicated by the arrows in
the previous panel). Preferential location of the peptide into the HG slab correlates with better 4E10 epitope recognition-blocking.
2526 A. Ivankin et al. / Biochimica et Biophysica Acta 1818 (2012) 2521–2528X-ray reﬂectivity (XR) experiments of lipid monolayers revealed that
Chol stimulatedMPERp reorientation (Fig. 4 and Table 2). The peptide
was located deeply into the acyl-chain region with low Chol content
(>8 Å), while insertion was preferentially at the head-group region
with high Chol content (≤8 Å) (Fig. 5 and Table 2). Thus, our data
are consistent with transient or stable lipidic pores being assembled
by MPERp preferentially inserting at the level of the acyl chain or
head-group regions, respectively [41]. Chol-promoted relocation
was accompanied by increases of the unit cell area, and of the area oc-
cupied by the peptide, and a reduction of the monolayer thickness
(Tables 1 and 2). Moreover, the process resulted in better exposure
of the 4E10 epitope at the surface of membranes (Fig. 5, and model
depicted in Fig. 6).
Area expansion and concomitant monolayer thinning are in line
with the idea that, in the presence of Chol, pore formation by
MPERp primarily results from the asymmetric increase of the mono-
layer surface and further generation of elastic stresses in the bilayer
[43–45] (Fig. 6). We surmise that the accumulated elastic energy,
which dissipates through pore-formation in vesicles [43], can be4E10
4E10A
B
- Accessible epitope
- Monolayer asymmetric
area expansion
- Bilayer thinning
Fig. 6. Model to explain MPER-induced bilayer perturbation and its dependence on Chol. A
cessibility to 4E10 epitope is hindered and the free peptides induce transient permeabiliz
shallower MPER insertion and increased accessibility to the 4E10 epitope. Moreover, the su
surmise that the elastic stress generated in bilayers by the expansion of one monolayer
pores [41,43]; and 2) in the context of the viral gp41, transmembrane domains lock MPER
dence for involvement of 5–7 trimers at the fusion site has been obtained by electron tomog
bulges (see reference [26] for a discussion on membrane fusion driven by curvature generacoupled to membrane merger in the context of the Env glycoprotein
complexes (see caption for Fig. 6). In that regard our results would
sustain previous Kozlov's model, which postulates that MPER inser-
tion into the external monolayer of the viral membrane could gener-
ate curvature, even when this element is in great part recruited into
the 6-HB [25]. According to these authors Trp 678, Trp 680 and Tyr
681 of the gp41, are exposed toward the membrane and well posi-
tioned to insert their side chains into the bilayer. Using a model for
membrane bending by hydrophobic insertions [45], one can estimate
the membrane curvature that these MPER residues generate by a
shallow insertion. One gp41 chain produces local curvature of
~0.65 nm−1; thus a gp41 trimer might stabilize a membrane cylinder
of about 15 nm diameter, which would facilitate fusion considerably.
Reconstructions of native Env glycoprotein particles either at the
viral surface of intact virions [46], or puriﬁed and detergent-
stabilized in solution [47], suggest that MPER might insert into the
viral envelope also in a native pre-fusion state. In the context of the
native Env “tripod” model derived from those studies, MPER would
submerge into the external membrane monolayer as an independentstable pores by free peptides
membrane bulges
by Env glycoprotein
free peptides induce
transient pores
) When Chol levels are low the peptide penetrates deeper into the monolayer, the ac-
ation of the bilayer [41]. B) Chol levels as those existing at the viral envelope lead to
rface occupied by each peptide increases and the monolayer thickness decreases. We
can be relaxed in two ways: 1) free peptides may generate toroidal, stable aqueous
sequences into a ring-like conﬁguration at the membrane interface. Experimental evi-
raphy [49]. Elastic stress is released in this case through the formation of the protruding
tion).
2527A. Ivankin et al. / Biochimica et Biophysica Acta 1818 (2012) 2521–2528element [46,48]. Our XR data suggest that MPER domainmight poten-
tially occupy larger membrane areas under those conditions (Fig. 4
and Table 2). Particularly, the canonical MPERp sequencemight occupy
an area three times larger than that calculated for the MPER region
exposed in the 6-HB [25], and this area would further increase in the
presence of high Chol concentrations (Table 2). Thus, our experimental
results complement Kozlov's model [25] by establishing the putative
pre-fusion conditions required for optimal induction of membrane
deformations by MPER inserted into the viral envelope. Firstly, they
identify the complete MPER sequence as an important determinant of
curvature generation. Secondly, they conﬁrm that the high Chol content
of the viral envelope ensures a more favorable level of insertion. Lower
Chol concentrations would result in deeper insertion of this element,
reduced interfacial occupancy and, consequently, limited thinning of
the external monolayer. These effects would translate into a lower
capacity for generating curvature at the viral envelope. Together, our
observations would be consistent with the putative adaptation of
MPER for actively deforming the Chol-enriched viral envelope as an
element of a “tripod”-like structure [46,48].Acknowledgements
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